Black Diamond Therapeutics, Inc. (BDTX)

NASDAQ: BDTX · Real-Time Price · USD

1.740

+0.040 (2.35%)

At close: Oct 15, 2026, 4:00 PM EDT

1.720

-0.020 (-1.15%)

After-hours: Oct 15, 2026, 7:30 PM EDT

BDTX Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Assets

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	19.19	20.99	36.44	56.22	34.32	65.8
Short-Term Investments	91.31	107.66	62.14	75.18	88.49	143.99
Cash & Short-Term Investments	110.51	128.65	98.58	131.4	122.81	209.79
Cash Growth	-22.63%	30.51%	-24.98%	7.00%	-41.46%	-33.41%
Prepaid Expenses	4.89	3.79	2.6	2.63	4.9	5.92
Total Current Assets	115.39	132.44	101.18	134.03	127.71	215.7
Property, Plant & Equipment	8.52	9.67	20.4	23.71	27.38	30.74
Other Long-Term Assets	1.12	0.9	1.07	0.82	1.17	1.24
Total Assets	125.03	143.01	122.64	158.57	156.26	247.68

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Accounts Payable	1.4	0.58	4.01	2.32	1.88	4.11
Accrued Expenses	10.56	11.44	13.16	14.21	10.54	19.22
Current Portion of Leases	3.88	3.71	3.4	3.11	2.84	0.32
Total Current Liabilities	15.84	15.73	20.57	19.65	15.26	23.64
Long-Term Leases	13.1	15.07	18.78	22.19	25.3	28.14
Total Liabilities	28.94	30.8	39.36	41.83	40.56	51.78

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Common Stock	0.01	0.01	0.01	0.01	0.01	0.01
Additional Paid-In Capital	579.83	576.84	570.36	534.19	452.5	440.13
Retained Earnings	-483.68	-464.74	-487.11	-417.43	-334.99	-243.82
Comprehensive Income & Other	-0.07	0.1	0.02	-0.03	-1.82	-0.41
Total Common Equity	96.09	112.21	83.29	116.74	115.7	195.9
Shareholders' Equity	96.09	112.21	83.29	116.74	115.7	195.9
Total Liabilities & Equity	125.03	143.01	122.64	158.57	156.26	247.68

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Total Debt	16.97	18.78	22.19	25.3	28.14	28.46
Net Cash (Debt)	93.54	109.87	76.39	106.1	94.67	181.33
Net Cash Growth	-23.38%	43.83%	-28.00%	12.08%	-47.79%	-40.81%
Net Cash Per Share	1.64	1.91	1.39	2.41	2.61	5.01
Filing Date Shares Outstanding	57.45	57.29	56.66	51.72	36.48	36.27
Total Common Shares Outstanding	57.45	57.14	56.64	51.65	36.43	36.23
Working Capital	99.55	116.71	80.6	114.39	112.45	192.06
Book Value Per Share	1.67	1.96	1.47	2.26	3.18	5.41
Tangible Book Value	96.09	112.21	83.29	116.74	115.7	195.9
Tangible Book Value Per Share	1.67	1.96	1.47	2.26	3.18	5.41
Machinery	-	-	0.02	0.02	0.83	0.82
Construction In Progress	-	-	-	-	-	0.15
Leasehold Improvements	1.59	1.59	2.51	2.51	2.51	2.44

SEC Filings: 10-K · 10-Q